MERREM IV Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Merrem Iv, and when can generic versions of Merrem Iv launch?
Merrem Iv is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in MERREM IV is meropenem. There are thirty-two drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the meropenem profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Merrem Iv
A generic version of MERREM IV was approved as meropenem by ACS DOBFAR on October 26th, 2011.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MERREM IV?
- What are the global sales for MERREM IV?
- What is Average Wholesale Price for MERREM IV?
Summary for MERREM IV
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Clinical Trials: | 15 |
| Patent Applications: | 4,958 |
| DailyMed Link: | MERREM IV at DailyMed |
Recent Clinical Trials for MERREM IV
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Wake Forest University Health Sciences | Phase 4 |
| Johns Hopkins University | Phase 2 |
| Hoffmann-La Roche | Phase 1 |
US Patents and Regulatory Information for MERREM IV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pfizer | MERREM IV | meropenem | INJECTABLE;INJECTION | 050706-001 | Jun 21, 1996 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Pfizer | MERREM IV | meropenem | INJECTABLE;INJECTION | 050706-003 | Jun 21, 1996 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MERREM IV
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | MERREM IV | meropenem | INJECTABLE;INJECTION | 050706-001 | Jun 21, 1996 | ⤷ Start Trial | ⤷ Start Trial |
| Pfizer | MERREM IV | meropenem | INJECTABLE;INJECTION | 050706-003 | Jun 21, 1996 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for MERREM IV
See the table below for patents covering MERREM IV around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | S6355514 | ⤷ Start Trial | |
| Japan | S601186 | NOVEL BETA-LACTAM COMPOUND AND ITS PREPARATION | ⤷ Start Trial |
| Spain | 532741 | ⤷ Start Trial | |
| Austria | 121402 | ⤷ Start Trial | |
| Japan | H0466872 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MERREM IV
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 2603514 | 19C1021 | France | ⤷ Start Trial | PRODUCT NAME: COMBINAISON DE VABORBACTAME, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, ET DE MEROPENEME, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, EN PARTICULIER DE MEROPENEME TRIHYDRATE; REGISTRATION NO/DATE: EU/1/18/1334 20181122 |
| 0126587 | SPC/GB95/030 | United Kingdom | ⤷ Start Trial | PRODUCT NAME: MEROPENEM OPTIONALLY IN THE FORM OF A HYDRATE AND /OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: IT 99/1994 19940817; UK 12619/0097 19950119; UK 12619/0098 19950119; UK 12619/0099 19950119; UK 12619/0100 19950119 |
| 3412676 | PA2020519,C3412676 | Lithuania | ⤷ Start Trial | PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120 |
| 3412676 | LUC00168 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: COMBINAISON DE VABORBACTAM, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, ET DE MEROPENEME, ET/OU D'UN SEL ET/OU D'UN HYDRATE DE CELUI-CI, EN PARTICULIER DE MEROPENEME TRIHYDRATE; AUTHORISATION NUMBER AND DATE: EU/1/18/1334 20181122 |
| 3412676 | PA2020519 | Lithuania | ⤷ Start Trial | PRODUCT NAME: VABORBAKTAMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO BEI MEROPENEMO IR (ARBA) JO DRUSKOS, IR (ARBA) HIDRATO, YPAC MEROPENEMO TRIHIDRATO, DERINYS; REGISTRATION NO/DATE: EU/1/18/1334 20181120 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Market Dynamics and Financial Trajectory for MERREM IV
More… ↓
